← Back to Search

Mokhuri intensive treatment for Spondylolisthesis

N/A

Waitlist Available

Led By Kiok Kim, Dr.

Research Sponsored by Kim Ki Ok

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 18th, 30th, 54th and 102th weeks

Awards & highlights

Study Summary

This trial is testing a new, intensive treatment program for pain relief that includes Chuna, acupuncture, and patient education. The goal is to see if this program is more effective than non-surgical conventional treatments like drugs, epidural injections, and physical therapy.

Eligible Conditions

Spondylolisthesis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 18th, 30th, 54th and 102th weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 18th, 30th, 54th and 102th weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 18th, 30th, 54th and 102th weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

0 to 100 Visual Analogue Scale (VAS) for low back pain

Secondary outcome measures

0 to 100 Visual Analogue Scale (VAS) for leg pain

Adverse event assessments

EQ-5D

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mokhuri intensive treatment groupExperimental Treatment1 Intervention

Patients in this arm will be treated with 35-week of Mokhuri intensive treatment program which compromise 10 sessions of acupuncture, Chuna and patient consultation during 5 weeks.

Group II: Non-surgical conventional treatment groupActive Control1 Intervention

Patients in this arm will be treated with 10 sessions of non-surgical conventional standard treatment including conventional drug treatment and injection treatment during 5 weeks.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicOTHER

3,213 Previous Clinical Trials

3,766,896 Total Patients Enrolled

1 Trials studying Spondylolisthesis

50 Patients Enrolled for Spondylolisthesis

Kim Ki OkLead Sponsor

Korea Health Industry Development InstituteOTHER_GOV

43 Previous Clinical Trials

86,233 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals beyond their fourth decade of life eligible for this research endeavor?

"Based on the established qualifications, this clinical trial allows for patients aged 19 or above and 78 or below to enroll."

Answered by AI

What are the eligibility criteria for participation in this clinical investigation?

"115 individuals between 19 and 78 are currently being recruited for this trialling, all of whom must meet the criteria such as weight less than 113.398 kgs and a height no taller than 6.890 ft (2.1 m). Patient's suffering from neurologic claudication or radicular pain lasting at least one year, not having received epidural injections in the past month nor undergone lumbar surgery, with neurogenic claudication while walking on treadmill at 1.5 mph is also required to be eligible for participation."

Answered by AI

Are there still vacancies available in this investigation for participants?

"The clinicaltrials.gov website states that this trial is not currently recruiting participants, with its original post date being December 15th 2017 and most recent update occurring on January 4th 2021. Despite this, 35 other studies are actively enlisting patients right now."

Answered by AI

Recent research and studies

MedicineJournal

The Effectiveness and Safety of Nonsurgical Integrative Interventions for Symptomatic Lumbar Spinal Spondylolisthesis

Kim, Kiok, Yousuk Youn, Sang Ho Lee, Jung Chul Choi, Jae Eun Jung, Jaehong Kim, Wenchun Qu, Jason Eldrige, and Tae-Hun Kim. 2018. “The Effectiveness and Safety of Nonsurgical Integrative Interventions for Symptomatic Lumbar Spinal Spondylolisthesis”. Medicine. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/md.0000000000010667.

clinicaltrials.govStudy

Korean Medicine for Symptomatic Lumbar Spinal Spondylolisthesis

Kim Ki Ok 2017. "Korean Medicine for Symptomatic Lumbar Spinal Spondylolisthesis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03107468.